Literature DB >> 26329536

Tetraspanin CD81 promotes tumor growth and metastasis by modulating the functions of T regulatory and myeloid-derived suppressor cells.

Felipe Vences-Catalán1, Ranjani Rajapaksa1, Minu K Srivastava1, Aurelien Marabelle1, Chiung-Chi Kuo1, Ronald Levy1, Shoshana Levy2.   

Abstract

Tumor cells counteract innate and adaptive antitumor immune responses by recruiting regulatory T cells (Treg) and innate myeloid-derived suppressor cells (MDSC), which facilitate immune escape and metastatic dissemination. Here we report a role in these recruitment processes for CD81, a member of the tetraspanin family of proteins that have been implicated previously in cancer progression. We found that genetic deficiency in CD81 reduced tumor growth and metastasis in two genetic mouse backgrounds and multiple tumor models. Mechanistic investigations revealed that CD81 was not required for normal development of Treg and MDSC but was essential for immunosuppressive functions. Notably, adoptive transfer of wild-type Treg into CD81-deficient mice was sufficient to promote tumor growth and metastasis. Our findings suggested that CD81 modulates adaptive and innate immune responses, warranting further investigation of CD81 in immunomodulation in cancer and its progression. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26329536     DOI: 10.1158/0008-5472.CAN-15-1021

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

1.  Open conformation of tetraspanins shapes interaction partner networks on cell membranes.

Authors:  Yihu Yang; Xiaoran Roger Liu; Zev J Greenberg; Fengbo Zhou; Peng He; Lingling Fan; Shixuan Liu; Guomin Shen; Takeshi Egawa; Michael L Gross; Laura G Schuettpelz; Weikai Li
Journal:  EMBO J       Date:  2020-08-16       Impact factor: 11.598

2.  Machine learning-assisted elucidation of CD81-CD44 interactions in promoting cancer stemness and extracellular vesicle integrity.

Authors:  Tujin Shi; Yang Shen; Nurmaa K Dashzeveg; Huiping Liu; Erika K Ramos; Chia-Feng Tsai; Yuzhi Jia; Yue Cao; Megan Manu; Rokana Taftaf; Andrew D Hoffmann; Lamiaa El-Shennawy; Marina A Gritsenko; Valery Adorno-Cruz; Emma J Schuster; David Scholten; Dhwani Patel; Xia Liu; Priyam Patel; Brian Wray; Youbin Zhang; Shanshan Zhang; Ronald J Moore; Jeremy V Mathews; Matthew J Schipma; Tao Liu; Valerie L Tokars; Massimo Cristofanilli
Journal:  Elife       Date:  2022-10-04       Impact factor: 8.713

3.  Tetraspanin CD81, a modulator of immune suppression in cancer and metastasis.

Authors:  Felipe Vences-Catalán; Ranjani Rajapaksa; Minu K Srivastava; Aurelien Marabelle; Chiung-Chi Kuo; Ronald Levy; Shoshana Levy
Journal:  Oncoimmunology       Date:  2015-12-18       Impact factor: 8.110

4.  Increased expression of CD81 is associated with poor prognosis of prostate cancer and increases the progression of prostate cancer cells in vitro.

Authors:  Yu Zhang; Haining Qian; An Xu; Ganggang Yang
Journal:  Exp Ther Med       Date:  2019-11-26       Impact factor: 2.447

5.  Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.

Authors:  Chuang Zhang; Danni Li; Ruoxi Yu; Ce Li; Yujia Song; Xi Chen; Yibo Fan; Yunpeng Liu; Xiujuan Qu
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

6.  CD81 Enhances Radioresistance of Glioblastoma by Promoting Nuclear Translocation of Rad51.

Authors:  Wang Zheng; Qianping Chen; Hongxia Liu; Songling Hu; Yuchuan Zhou; Yang Bai; Jianghong Zhang; Yan Pan; Chunlin Shao
Journal:  Cancers (Basel)       Date:  2021-04-21       Impact factor: 6.639

Review 7.  Fibrocytes: A Novel Stromal Cells to Regulate Resistance to Anti-Angiogenic Therapy and Cancer Progression.

Authors:  Hisatsugu Goto; Yasuhiko Nishioka
Journal:  Int J Mol Sci       Date:  2017-12-29       Impact factor: 5.923

8.  A non-internalizing antibody-drug conjugate based on an anthracycline payload displays potent therapeutic activity in vivo.

Authors:  Alberto Dal Corso; Rémy Gébleux; Patrizia Murer; Alex Soltermann; Dario Neri
Journal:  J Control Release       Date:  2017-09-01       Impact factor: 9.776

9.  Targeting the tetraspanin CD81 reduces cancer invasion and metastasis.

Authors:  Felipe Vences-Catalán; Ranjani Rajapaksa; Chiung-Chi Kuo; Caitlyn L Miller; Anderson Lee; Vishnu C Ramani; Stefanie S Jeffrey; Ronald Levy; Shoshana Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-15       Impact factor: 11.205

10.  Stroma-derived but not tumor ADAMTS1 is a main driver of tumor growth and metastasis.

Authors:  Rubén Fernández-Rodríguez; Francisco Javier Rodríguez-Baena; Estefanía Martino-Echarri; Carlos Peris-Torres; María Del Carmen Plaza-Calonge; Juan Carlos Rodríguez-Manzaneque
Journal:  Oncotarget       Date:  2016-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.